5 authorised products containing Cyclophosphamide monohydrate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Cyclophosphamide Seacross 1000 mg powder for solution for injection/infusion PA22766/013/003 |
Cyclophosphamide monohydrate | Seacross Pharma (Europe) Limited | Not marketed |
| Cyclophosphamide Seacross 200 mg powder for solution for injection/infusion PA22766/013/001 |
Cyclophosphamide monohydrate | Seacross Pharma (Europe) Limited | Not marketed |
| Cyclophosphamide Seacross 2000 mg powder for solution for injection/infusion PA22766/013/004 |
Cyclophosphamide monohydrate | Seacross Pharma (Europe) Limited | Not marketed |
| Cyclophosphamide Seacross 500 mg powder for solution for injection/infusion PA22766/013/002 |
Cyclophosphamide monohydrate | Seacross Pharma (Europe) Limited | Not marketed |
| Endoxana Coated Tablets 50 mg PA2299/027/003 |
Cyclophosphamide monohydrate | Baxter Holding B.V. | Marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.